Home / Current Issue / Paper 1718614
How Do Haemophilus Influenzae, Neisseria Meningitidis, And Streptococcus Pneumoniae Differ in Their Age-Specific Global Mortality Rates from Meningitis Between 2019 And 2023?
Subject area: Biological & Medical Sciences · Area of research: Infectious Disease Epidemiology
DOI: 10.64388/IREV9I12-1718614
Abstract
Background: Bacterial meningitis remains a major cause of mortality in neonates and infants globally, with disease severity, mortality, and long-term outcomes varying by both causative pathogen and age. Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae account for a substantial proportion of cases worldwide, although their relative contribution varies across regions and vaccination settings. Despite this, comprehensive comparisons of age-specific mortality patterns across these pathogens using recent global burden estimates remain limited. Methods: Global Burden of Disease (GBD) 2019–2023 estimates were analysed to assess age-specific mortality rates attributable to Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae. Data were extracted for 25 standard GBD age groups, ranging from early neonatal (0–6 days) to ≥95 years, at the global level for both sexes combined. Descriptive analyses were performed to evaluate temporal trends and cross-pathogen differences across age strata. Results: Mortality burden was highest in neonates, peaking within the first week of life, and declined sharply after the first year. S. pneumoniae accounted for the greatest share across all age groups, followed by N. meningitidis and H. influenzae, a ranking that remained consistent throughout the life course. A secondary rise in mortality was observed in individuals aged 95 and older. Between 2019 and 2023, mortality rates declined across all three pathogens, with the most pronounced reduction seen in H. influenzae.
References
[1] Anouk M Oordt-Speets, Renee Bolijn, Rosa C van Hoorn, Amit Bhavsar, Moe H Kyaw; “Global etiology of bacterial meningitis: A systematic review and meta-analysis” PLoS ONE, 2018. https://pubmed.ncbi.nlm.nih.gov/29889859/
[2] Jun Li, Xiang Li, Shunhong Luo, Haishen Zhou “Global, regional, and national burden of meningitis among children, 1990-2021: An analysis of the global burden of disease study 2021” PLoS ONE, 2025. https://pubmed.ncbi.nlm.nih.gov/40554606/
[3] Jay J Park, Sandhya Narayanan, Jakov Tiefenbach, Ivana Lukšić, Boni Maxime Ale, Davies Adeloye, Igor Rudan “Estimating the global and regional burden of meningitis in children caused by Haemophilus influenzae type b: A systematic review and meta-analysis” J Glob Health 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC8893283/
[4] Brian Wahl, PhD, Prof Katherine L O'Brien, MD; Adena Greenbaum, MD; Anwesha Majumder, MHS; Li Liu, PhD; Yue Chu, MSPH; Ivana Lukšić, MD; Prof Harish Nair, PhD; David A McAllister, MD; Prof Harry Campbell, MD; Prof Igor Rudan, MD; Prof Robert Black, MD; Maria Deloria Knoll, PhD “Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15” The Lancet Global Health, vol. 6 issue 7. https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(18)30247-X/fulltext
[5] K M Bisgard, A Kao, J Leake, P M Strebel, B A Perkins, M Wharton “Haemophilus influenzae invasive disease in the United States, 1994-1995: near disappearance of a vaccine-preventable childhood disease.” Emerg Infect Dis. 1998. https://pmc.ncbi.nlm.nih.gov/articles/PMC2640137/
[6] Anar Andani, Victoria Abbing-Karahagopian, Justina Kavaliauskaite, Thierry Oliver Schaffner, Woo-Yun Sohn, Maria Gabriela Graña, Helen Marshall, Federico Martinon-Torres, Paolo Bonanni, Rino Rappuoli, Muhamed-Kheir Taha. “Invasive meningococcal disease in adolescents in Europe and select geographies: Disease burden, unmet medical need, and optimizing prevention.” Human Vaccines & Immunotherapeutics 2025 https://www.tandfonline.com/doi/full/10.1080/21645515.2025.2574129
[7] Erik Backhaus, Stefan Berg, Rune Andersson, Gunilla Ockborn, Petter Malmström, Mats Dahl, Salmir Nasic, Birger Trollfors. “Epidemiology of invasive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age, gender and risk factors.” BMC Infect Dis 16, 367, 2016 https://link.springer.com/article/10.1186/s12879-016-1648-2
[8] Anna Skoczyńska, Izabela Waśko, Alicja Kuch, Marcin Kadłubowski, Agnieszka Gołębiewska, Małgorzata Foryś, Marlena Markowska, Patrycja Ronkiewicz, Katarzyna Wasiak, Aleksandra Kozińska, Bożena Matynia, Waleria Hryniewicz and participants of a laboratory-based surveillance of community acquired invasive bacterial infections (BINet). “A Decade of Invasive Meningococcal Disease Surveillance in Poland.” PLOS ONE 8(8), 2013 https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0071943
How to cite this paper
@article{1718614,
author = {Aarush Aditya Parulkar},
title = {How Do Haemophilus Influenzae, Neisseria Meningitidis, And Streptococcus Pneumoniae Differ in Their Age-Specific Global Mortality Rates from Meningitis Between 2019 And 2023?},
journal = {Iconic Research And Engineering Journals},
year = {2026},
volume = {9},
number = {12},
pages = {401-407},
issn = {2456-8880},
url = {https://www.irejournals.com/formatedpaper/1718614.pdf},
abstract = {Background:
Bacterial meningitis remains a major cause of mortality in neonates and infants globally, with disease severity, mortality, and long-term outcomes varying by both causative pathogen and age. Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae account for a substantial proportion of cases worldwide, although their relative contribution varies across regions and vaccination settings. Despite this, comprehensive comparisons of age-specific mortality patterns across these pathogens using recent global burden estimates remain limited.
Methods:
Global Burden of Disease (GBD) 2019–2023 estimates were analysed to assess age-specific mortality rates attributable to Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae. Data were extracted for 25 standard GBD age groups, ranging from early neonatal (0–6 days) to ≥95 years, at the global level for both sexes combined. Descriptive analyses were performed to evaluate temporal trends and cross-pathogen differences across age strata.
Results:
Mortality burden was highest in neonates, peaking within the first week of life, and declined sharply after the first year. S. pneumoniae accounted for the greatest share across all age groups, followed by N. meningitidis and H. influenzae, a ranking that remained consistent throughout the life course. A secondary rise in mortality was observed in individuals aged 95 and older. Between 2019 and 2023, mortality rates declined across all three pathogens, with the most pronounced reduction seen in H. influenzae.},
month = {June},
doi = {https://doi.org/10.64388/IREV9I12-1718614}
}